Use of recombinant factor VIIa in a preterm infant with coagulopathy and subdural hematoma

被引:6
|
作者
Altuncu, Emel [1 ]
Berrak, Su [1 ]
Bilgen, Huelyya [1 ]
Yurdakul, Ziya [1 ]
Canpolat, Cengiz [1 ]
Oezek, Eren [1 ]
机构
[1] Marmara Univ, Sch Med, Dept Pediat, Div Neonatol & Hematol, Istanbul, Turkey
来源
关键词
factor VIIa; preterm; bleeding diasthesis;
D O I
10.1080/14767050701411935
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Activated recombinant factor VIIa was administered to a preterm infant with bleeding diasthesis and a huge subdural hematoma that could not be controlled by the blood products. The coagulation tests were normalized the following day. Recombinant factor VIIa can be a choice in selected cases with intractable bleedings unesponsive to conventional replacement therapy.
引用
收藏
页码:627 / 629
页数:3
相关论文
共 50 条
  • [1] Use of recombinant factor VIIa in infants with severe coagulopathy
    Fontaine M.J.
    Lazarchick J.
    Taylor S.
    Annibale D.
    [J]. Journal of Perinatology, 2004, 24 (5) : 310 - 311
  • [2] Successful use of recombinant factor VIIa in a preterm infant with life-threatening haematuria
    Faust, Kirstin
    Troeger, Birthe
    Kahl, Fritz
    Schumacher, Marius
    Goepel, Wolfgang
    Haertel, Christoph
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (07) : 601 - 604
  • [3] Recombinant Activated Factor VII For Surgical Evacuation of Subdural Hematoma In Patients With Coagulopathy
    Hallevi, Hen
    Adejuwon, Ola
    Escobar, Miguel A.
    Chong, Kenneth
    Allison, Teresa A.
    [J]. STROKE, 2009, 40 (04) : E236 - E236
  • [4] INTRAOPERATIVE APPLICATION EXPERIENCE OF VIIA RECOMBINANT HUMAN FACTOR IN PATIENTS WITH ITP AND COMPLICATED SUBDURAL HEMATOMA
    Yeghiazaryan, M. I.
    Museyan, L. A.
    Fanardjyan, R. V.
    Khachatryan, T. N.
    Jilavyan, M. V.
    [J]. ARCHIV EUROMEDICA, 2011, 3 : 86 - 89
  • [5] Use of recombinant factor VIIa in pediatric patients with liver failure and severe coagulopathy
    Atkison, PR
    Jardine, L
    Williams, S
    Barr, RM
    Quan, D
    Wall, W
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 1091 - 1093
  • [6] Successful reversal of deleterious coagulopathy by recombinant factor VIIa
    Haas, T
    Innerhofer, P
    Kühbacher, G
    Fries, D
    [J]. ANESTHESIA AND ANALGESIA, 2005, 100 (01): : 54 - 58
  • [7] Recombinant factor VIIa therapy in a patient on long term anticoagulant treatment with a bleeding and acute subdural hematoma
    Kovac, Natasa
    Gopcevic, Aleksandar
    Kovac, Josip
    Gacina, Petar
    Novkoski, Mladen
    [J]. SIGNA VITAE, 2007, 2 (02) : 25 - 26
  • [8] Recombinant activated factor VIIa use in massive transfusion and Coagulopathy unresponsive to conventional therapy
    Gowers, CJD
    Parr, MJA
    [J]. ANAESTHESIA AND INTENSIVE CARE, 2005, 33 (02) : 196 - 200
  • [9] Management of 2 patients with subdural hematoma and Coagulopathy with recombinant human activated Factor VII (Novoseven, rVIIa).
    Abu-Hajir, M
    Hollowell, J
    Nagargoje, G
    [J]. BLOOD, 2001, 98 (11) : 79B - 79B
  • [10] Successful use of recombinant factor VIIa in reversal of life threatening bleeding caused by coagulopathy
    Muslimani, AA
    Walia, HK
    Ahluwalia, MS
    Daneschvar, HL
    Daw, HA
    [J]. BLOOD, 2005, 106 (11) : 100B - 100B